Corcept Therapeutics (CORT) Income After Tax (2010 - 2026)
Corcept Therapeutics' Income After Tax was $126.81 million in Q3 2026, up 544.7% from $19.67 million a year earlier and up 195.0% from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Income After Tax (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Corcept Therapeutics' Income After Tax was $162.37 million through Sep 30, 2026, up 52.9% year-over-year; for FY2025, it came in at $99.65 million, down 29.4% from FY2024.
- Income After Tax shows a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- In earlier years, Income After Tax was $141.21 million in FY2024 (+33.0%), $106.14 million in FY2023 (+4.7%), $101.42 million in FY2022 (-9.9%) and $112.51 million in FY2021 (+6.1%).
- The Q3 2026 figure marks the highest quarterly Income After Tax in data going back to Q2 2010.
- Compared with a year earlier, Income After Tax was higher in two of the last seven quarters, with growth averaging 65.5%.
- The best year-over-year quarter for Income After Tax over five years was Q3 2026 (growth of 544.7%); the worst was Q3 2025 (a decline of 58.3%).
- Per Business Quant data, CORT's Income After Tax in the three quarters before Q3 2026 was $42.99 million (Q2 2026), -$31.72 million (Q1 2026) and $24.29 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 126.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 126.81 Mn |
| Jun 30, 2026 | 42.99 Mn |
| Mar 31, 2026 | -31.72 Mn |
| Dec 31, 2025 | 24.29 Mn |
| Sep 30, 2025 | 19.67 Mn |
| Jun 30, 2025 | 35.19 Mn |
| Mar 31, 2025 | 20.55 Mn |
| Dec 31, 2024 | 30.78 Mn |
| Sep 30, 2024 | 47.21 Mn |
| Jun 30, 2024 | 35.49 Mn |
| Mar 31, 2024 | 27.76 Mn |
| Dec 31, 2023 | 31.39 Mn |
| Sep 30, 2023 | 31.38 Mn |
| Jun 30, 2023 | 27.53 Mn |
| Mar 31, 2023 | 15.83 Mn |
| Dec 31, 2022 | 16.60 Mn |
| Sep 30, 2022 | 34.61 Mn |
| Jun 30, 2022 | 27.36 Mn |
| Mar 31, 2022 | 22.75 Mn |
| Dec 31, 2021 | 32.05 Mn |
API Access
Corcept Therapeutics Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();